Managers / Q4 2022 · view latest →
Prossimo Advisors, LLC
CIK 0001965307 · 1150 OSOS STREET, SUITE 208, SAN LUIS OBISPO, CA, 93401 · 805-548-2800
Summary
Prossimo Advisors, LLC reported $43M in U.S.-listed holdings across 53 positions for Q4 2022.
Its largest position, Shockwave Med, represents 8.9% of the portfolio.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 80.8% · $35M
- ETP · 12.5% · $5M
- REIT · 4.7% · $2M
- ADR · 2.0% · $846,000
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SHOCKWAVE MED INC | NEW | +18.8K | 18.8K | +$4M | $4M |
| VVISA INC | NEW | +18.1K | 18.1K | +$4M | $4M |
| HYDVANECK ETF TRUST | NEW | +49.5K | 49.5K | +$3M | $3M |
| GOOGLALPHABET INC | NEW | +24.7K | 24.7K | +$2M | $2M |
| COSTCOSTCO WHSL CORP NEW | NEW | +3.8K | 3.8K | +$2M | $2M |
| UNHUNITEDHEALTH GROUP INC | NEW | +3.2K | 3.2K | +$2M | $2M |
| MAMASTERCARD INCORPORATED | NEW | +3.9K | 3.9K | +$1M | $1M |
| JPMJPMORGAN CHASE & CO | NEW | +8.3K | 8.3K | +$1M | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $16M | 24 | Apr 29, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $16M | 36 | Feb 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $14M | 31 | Oct 28, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $125M | 144 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $133M | 134 | May 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $138M | 135 | Jan 31, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $137M | 140 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $110M | 126 | Jul 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $52M | 60 | May 3, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $47M | 59 | Feb 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $42M | 56 | Nov 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $104M | 125 | Jul 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $41M | 54 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $43M | 53 | Feb 9, 2023 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- RBC028-11396
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.